Close Menu

NEW YORK ─ Biotech firm Medix Biochemica said Friday that it has acquired EastCoast Bio (ECB), a provider of antigens, antibodies, and blocking buffers for the in vitro diagnostic manufacturing industry, and Biostride, a developer and maker of antibodies and antigens for the IVD industry for drugs of abuse and hormone testing.

Financial and other terms of the acquisitions were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.